SNDT WOMEN'S UNIVERSITY

BMK Knowledge Resource Centre

Vithaldas Vidyavihar, Juhu Tara Road,
Santacruz (West) Mumbai - 400049

Anti-Cancer Potential of Sinensetin, a Bioactive Compound against Human Cervical Carcinoma Cells via its Molecular Mechanism of Apoptosis (Record no. 130068)

MARC details
000 -LEADER
fixed length control field 02343nam a2200181 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241108b |||||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Abdulaziz S. Alothaim
245 ## - TITLE STATEMENT
Title Anti-Cancer Potential of Sinensetin, a Bioactive Compound against Human Cervical Carcinoma Cells via its Molecular Mechanism of Apoptosis
300 ## - PHYSICAL DESCRIPTION
Extent P-145-153
520 ## - SUMMARY, ETC.
Summary, etc. biblio.abstract Cancer is ranked among the world's leading causes of death in 2020 with an estimated 10 million recorded fatalities attributable to the disease. After breast, colorectal, and lung cancer, cervical cancer is the fourth most frequent disease in women worldwide. Each year, there are 6,00,000 new cases and 3,40,000 fatalities due to cervical cancer. HPV (Human Papilloma Virus), the main cause of cervical cancer, spreads to the cervix's epithelial cells during intercourse. Aim: The use of natural products in conjunction with chemotherapy treatments is seen to be a viable alternative to chemotherapy medications. Materials and Methods: The purpose of this study was to determine the cytotoxic and apoptotic effects of sinensetin on HepG2 cells. For the determination of cytotoxicity using XXT assay, and LDH release assay, generation of reactive oxygen species was identified by DCFH-DA staining, Nuclear DNA damage was identified by DAPI staining, and apoptotic cell death was detected through AO/EB dual staining, and estimation of pro-apoptotic markers using ELISA method. Results: In the current investigation, the potential of Sinensetin as an anticancer agent for cervical cancer was evaluated. The results showed that apoptosis was induced by Sinensetin in HeLa cells by triggering ROS pathway, DNA damage, and caspase pathway. The cell viability of HeLa cells was reduced with increased concentration of Sinensetin. The LDH level was increased with increased concentration of Sinensetin. Conclusion: All these results suggest that Sinensetin can be used as a potent anticancer drug for cervical cancer.
654 ## - SUBJECT ADDED ENTRY--FACETED TOPICAL TERMS
Subject <a href=" Cervical cancer"> Cervical cancer</a>
-- <a href=" HeLa cells"> HeLa cells</a>
-- <a href="Sinensetin">Sinensetin</a>
-- <a href=" Apoptosis"> Apoptosis</a>
-- <a href=" Reactive oxygen species"> Reactive oxygen species</a>
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Abdulaziz S. Alothaim
773 0# - HOST ITEM ENTRY
Host Biblionumber 125266
Host Itemnumber 109601
Place, publisher, and date of publication Banglore Association of Pharmaceutical Tearchers of India
Title Indian Journal of Pharmaceutical Education and Research
International Standard Serial Number 0019-5464
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
773 0# - HOST ITEM ENTRY
-- JP44
942 ## - ADDED ENTRY ELEMENTS (KOHA)
-- ddc
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Location (home branch) Sublocation or collection (holding branch) Date acquired Koha issues (times borrowed) Piece designation (barcode) Koha date last seen Price effective from Koha item type
    Dewey Decimal Classification     SNDT Juhu SNDT Juhu 08/11/2024   jp44.16 08/11/2024 08/11/2024 Journal Article